Skip to main content
icon for ¿Casos de sarampión en EE. UU. antes del 31 de agosto?

¿Casos de sarampión en EE. UU. antes del 31 de agosto?

icon for ¿Casos de sarampión en EE. UU. antes del 31 de agosto?

¿Casos de sarampión en EE. UU. antes del 31 de agosto?

$11,856 Vol.

31 ago 2026
Polymarket

$11,856 Vol.

Polymarket

2800+

$1,802 Vol.

100%

2825+

$1,759 Vol.

100%

2850+

$3,382 Vol.

100%

2900+

$1,686 Vol.

100%

2950+

$3,228 Vol.

2%

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.**Ongoing measles transmission driven by declining MMR vaccination coverage has pushed confirmed U.S. cases to 2,903 as of August 27, 2026, per CDC data, with active outbreaks continuing to add dozens of cases weekly.** Ninety-four percent of infections are among unvaccinated or unknown-status individuals, concentrated in states including Pennsylvania, Ohio, Utah, and South Carolina, where community spread persists despite some earlier outbreaks winding down. This marks the highest annual total since 1991 and exceeds the full-year 2025 count of 2,289, reflecting eroded herd immunity as kindergarten MMR rates fell to 92.4% nationally. CDC weekly updates through late August, including any final rash-onset reports, will determine the precise August 31 tally used for market resolution, with traders monitoring ongoing surveillance for late additions.

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.

Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volumen
$11,856
Fecha de finalización
1 sep 2026
Mercado abierto
Aug 24, 2026, 10:08 AM ET
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.**Ongoing measles transmission driven by declining MMR vaccination coverage has pushed confirmed U.S. cases to 2,903 as of August 27, 2026, per CDC data, with active outbreaks continuing to add dozens of cases weekly.** Ninety-four percent of infections are among unvaccinated or unknown-status individuals, concentrated in states including Pennsylvania, Ohio, Utah, and South Carolina, where community spread persists despite some earlier outbreaks winding down. This marks the highest annual total since 1991 and exceeds the full-year 2025 count of 2,289, reflecting eroded herd immunity as kindergarten MMR rates fell to 92.4% nationally. CDC weekly updates through late August, including any final rash-onset reports, will determine the precise August 31 tally used for market resolution, with traders monitoring ongoing surveillance for late additions.

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.

Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volumen
$11,856
Fecha de finalización
1 sep 2026
Mercado abierto
Aug 24, 2026, 10:08 AM ET
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.

Cuidado con los enlaces externos.

Preguntas frecuentes

"¿Casos de sarampión en EE. UU. antes del 31 de agosto?" es un mercado de predicción en Polymarket con 5 resultados posibles donde los operadores compran y venden acciones según lo que creen que sucederá. El resultado líder actual es "2800+" con 100%, seguido de "2825+" con 100%. Los precios reflejan probabilidades en tiempo real de la comunidad. Por ejemplo, una acción cotizada a 100¢ implica que el mercado colectivamente asigna una probabilidad de 100% a ese resultado. Estas probabilidades cambian continuamente a medida que los operadores reaccionan a nuevos desarrollos. Las acciones del resultado correcto son canjeables por $1 cada una tras la resolución del mercado.

A día de hoy, "¿Casos de sarampión en EE. UU. antes del 31 de agosto?" ha generado $11.9K en volumen total de trading desde que el mercado se lanzó el Aug 24, 2026. Este nivel de actividad refleja un fuerte compromiso de la comunidad de Polymarket y ayuda a garantizar que las probabilidades actuales estén respaldadas por un amplio grupo de participantes del mercado. Puedes seguir los movimientos de precios en vivo y operar en cualquier resultado directamente en esta página.

Para operar en "¿Casos de sarampión en EE. UU. antes del 31 de agosto?", explora los 5 resultados disponibles en esta página. Cada resultado muestra un precio actual que representa la probabilidad implícita del mercado. Para tomar una posición, selecciona el resultado que consideres más probable, elige "Sí" para operar a favor o "No" para operar en contra, introduce tu cantidad y haz clic en "Operar". Si tu resultado elegido es correcto cuando el mercado se resuelve, tus acciones de "Sí" pagan $1 cada una. Si es incorrecto, pagan $0. También puedes vender tus acciones en cualquier momento antes de la resolución.

El favorito actual para "¿Casos de sarampión en EE. UU. antes del 31 de agosto?" es "2800+" con 100%, lo que significa que el mercado asigna una probabilidad de 100% a ese resultado. El siguiente resultado más cercano es "2825+" con 100%. Estas probabilidades se actualizan en tiempo real a medida que los operadores compran y venden acciones. Vuelve con frecuencia o guarda esta página en marcadores.

Las reglas de resolución para "¿Casos de sarampión en EE. UU. antes del 31 de agosto?" definen exactamente qué debe ocurrir para que cada resultado sea declarado ganador, incluyendo las fuentes de datos oficiales utilizadas para determinar el resultado. Puedes revisar los criterios de resolución completos en la sección "Reglas" en esta página sobre los comentarios. Recomendamos leer las reglas cuidadosamente antes de operar, ya que especifican las condiciones exactas, casos especiales y fuentes.